rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2008-6-13
|
pubmed:abstractText |
We reported recently the induction of selective iodide uptake in prostate cancer cells (LNCaP) by prostate-specific antigen (PSA) promoter-directed sodium iodide symporter (NIS) expression that allowed a significant therapeutic effect of (131)I. In the current study, we studied the potential of the high-energy alpha-emitter (211)At, also transported by NIS, as an alternative radionuclide after NIS gene transfer in tumors with limited therapeutic efficacy of (131)I due to rapid iodide efflux.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1619-7070
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1272-81
|
pubmed:meshHeading |
pubmed-meshheading:18404268-Animals,
pubmed-meshheading:18404268-Astatine,
pubmed-meshheading:18404268-Cell Line, Tumor,
pubmed-meshheading:18404268-Humans,
pubmed-meshheading:18404268-Male,
pubmed-meshheading:18404268-Mice,
pubmed-meshheading:18404268-Mice, Nude,
pubmed-meshheading:18404268-Neoplasm Transplantation,
pubmed-meshheading:18404268-Promoter Regions, Genetic,
pubmed-meshheading:18404268-Prostate-Specific Antigen,
pubmed-meshheading:18404268-Prostatic Neoplasms,
pubmed-meshheading:18404268-Recombinant Proteins,
pubmed-meshheading:18404268-Symporters,
pubmed-meshheading:18404268-Transfection,
pubmed-meshheading:18404268-Transplantation, Heterologous,
pubmed-meshheading:18404268-Tumor Stem Cell Assay
|
pubmed:year |
2008
|
pubmed:articleTitle |
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer.
|
pubmed:affiliation |
Department of Internal Medicine II, Ludwig-Maximilians-University, Munich, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|